Skip to Navigation
Skip to Main Content
Skip to Related Content
to view your mail
Yahoo Finance Plus
U.S. markets closed
CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
9,995 reactions on $CRSP conversation
Sign in to post a message.
Market will recognize this sector is less associated with inflation and war
Here’s how people got wiped on GME. Trying to stay short until bankruptcy, when bankruptcy wasn’t on the table. Now I see a bunch of biotech with high short interest at all time lows. Some biotech is now under $500 mil market cap but they don’t have debt, How much lower do you want? There’s a bunch $NVTA $BLI $CRSP, etc
The news wire shows another strategic hire of Dr. P.K Morrow for the final stretch to regulatory approval. Don't miss this important clue. Go CRSP, Goodluck to All CRSP faithful.
after selling at $63 at loss i bought twice amount of shares in $44.
Lets hope it does not look back anymore.
Data to be presented at EHA. The abstract, as of December 6, 15 of the 17 patients with T-cell lymphoma were able to be evaluated with CTX130. The overall response rate was 71% with 29% of patients experiencing a complete response. It had an acceptable safety profile.
Question: If gene editing is one-and-done, does the longer-term revenue stream from an effective therapy come only from new patients?
To invest in a company and make money is great. To invest in a company that cures diseases is heavenly.
CRSP stock price below $50 is a giveaway and a no brainer. Load up if you can and you'll be glad by end of the year.
$CRSP is one of my favorite stocks in $ARKG ... so I decided to just buy this at the open instead of ARKG.
Can you say "over-emotional panic selling?" It was just insane that this dumped all the way to the low $40s. I wasn't really expecting this to become a core holding of mine. But when it crashed last week, without too much thought I just bought shares in the chaos.
6 on going clinical trials going on, and the analyst move price targets down.
With 2.2 billion cash with 3.5 bill mc, time to accumulate
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the 2022 Bank of America Healthcare Conference on Wednesday, May 11, 2022, at 4:40 p.m. PT.
Can’t find the right stocks to trade? I have the fix for free (
Cost basis is 125…wake me up in 5 years
Guys, check out (
). They have been crushing it lately while CRSP barley does anything at all.
If you're not excited enough about CRSP, then see some their ongoing efforts to cure Type 1 diabetes
"WHERE IS CRSP EARNINGS????"
CRISPR THERAPEUTICS IS IN THE RESEARCH & DEVELOPEMENT STAGE.
APPLYING FOR FDA APPROVAL, 4TH QTR FOR CTX001
CRSP / CRBU / NTLA
SUPPORT THE NOBEL LAUREATES.
NOT THE BROAD
This is the most valuable car in the world
Rare Mercedes beats out Ferrari in record auction bid
Yahoo Finance Video
Coca-Cola unveils brand-new bottles with caps attached, hoping to curb recycling concerns
© 2022 Yahoo. All rights reserved.
About Our Ads